Table 6.
Data at T1 |
Missing data at T1 |
p-valuea |
|||
---|---|---|---|---|---|
N/Median | %/IQR | N/Median | %/IQR | ||
Male Gender** | 36 | 59 | 31 | 64.6 | 0.30 |
ICU hospitalization | 9 | 14.8 | 9 | 18.8 | 0.58 |
Psychiatric follow up | 20 | 47.6 | 6 | 27.3 | 0.18 |
PDEQ | |||||
Positive PDEQ at T0 | 22 | 36.1 | 27 | 56.3 | 0.04 |
PDEQ score at T0 | 12 | 10–18 | 15.5 | 12–27 | 0.01 |
PCL-5 | |||||
PCL-5 score at T0 | 10 | 3–18 | 14.5 | 3–30 | 0.08 |
Positive PCL-5 at T0 | 5 | 8.2 | 10 | 23.8 | 0.04 |
HADS for anxiety | |||||
HADS-A score at T0 | 5 | 3–8 | 6 | 4–9 | 0.19 |
Positive HADS-A at T0 | 7 | 11.5 | 10 | 21.3 | 0.17 |
HADS for depression | |||||
HADS-D score at T0 | 3 | 1–6 | 4 | 1–11 | 0.21 |
Positive HADS-D at T0 | 7 | 11.5 | 13 | 27.7 | 0.03 |
Using Chi2 or Wilcoxon test.